-
The merger and acquisition activity has increased by 2025, with a 29% increase in the value of the agreement.
-
Goldman Sachs predicts another 15% increase in mergers and acquisition agreements in 2026, which increases the valuations of the candidates.
-
It marked a list of companies that sees as fusion and acquisition objectives. Here are the six that believes that they are more likely to be bought.
The activity of mergers and acquisitions has been recovered in 2025, and the outbreak of the agreements has rewarded companies in the sights of merchants.
This week marked a particularly transcendental development in the world of mergers and acquisitions, with Electronic Arts it will be taken privately by a group of investors in what will be the largest leverage purchase in history. The action shot in the news, more than 20% in both days since the news was announced.
EA is the greatest and most recent example, but other actions have also shot themselves in the emotion of this year. In addition, there is a whole universe of actions that could be acquired in the next 12 months that investors should have in their radar.
A basket of actions that could be possible candidates for mergers and acquisitions have increased with the new wave of activity of agreement this year, and is defeating S&P 1500 for seven percentage points since the beginning of September, said Goldman Sachs on Monday.
The bank said that the dollars value of the M&A offers increases by 29% year after year, while the number of agreements reached in 2025 has increased 8%. Goldman expects the number of new agreements to grow in another 15% in 2026.
With more barrel agreements, the Bank highlighted six actions that believe they have 30% to 50% chance of being an objective for M&A in the next 12 months. The actions are the most likely objectives among a group of 49 companies that the bank considers candidates.
“We hope that the activity of OPI and M&A increases in 2026 along with accelerating the economic growth of the United States, improving the confidence of the CEO and a increasing capital market,” David Kostin wrote, the main American capital strategist of the bank, wrote in the note.
These are the most likely objectives of the bank for commerce.
INMANT
Heart: INSM
Sector: Health care
MARKET CAUT: $ 28.8 billion
Total return to date: 96%
Madrigales pharmacists
Heart: MDGL
Sector: Health care
MARKET CAUT: $ 9.5 billion
Total return to date: 8%
Krystal Biotechnology
Heart: Krys
Sector: Health care
MARKET CAUT: $ 8.8 billion
Total return to date: 3%
Mineral therapy
Heart: Mlys
Sector: Health care
MARKET CAUT: $ 4.9 billion
Total return to date: 213%
TripAdvisor
Heart: JOURNEY
Sector: Communication services
MARKET CAUT: $ 4.9 billion
Total return to date: 15%
Vera therapy
Heart: Vera
Sector: Health care
MARKET CAUT: $ 4.8 billion
(Tagstotranslate) Objectives of Goldman Sachs
Source link